Palisade Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.55M Buy
35,395
+196
+0.6% +$22.9K 0.42% 61
2026
Q1
$4.23M Sell
35,199
-85
-0.2% -$9.81K 0.43% 62
2025
Q4
$3.71M Buy
35,284
+1,161
+3% +$109K 0.36% 65
2025
Q3
$2.86M Sell
34,123
-63
-0.2% -$5.19K 0.27% 74
2025
Q2
$2.71M Buy
34,186
+830
+2% +$66K 0.27% 75
2025
Q1
$2.99M Buy
33,356
+385
+1% +$35.9K 0.31% 72
2024
Q4
$3.28M Buy
32,971
+5,657
+21% +$583K 0.33% 66
2024
Q3
$3.1M Buy
27,314
+133
+0.5% +$15.8K 0.3% 70
2024
Q2
$3.37M Sell
27,181
-15
-0.1% -$1.93K 0.35% 67
2024
Q1
$3.59M Sell
27,196
-20
-0.1% -$2.46K 0.35% 67
2023
Q4
$2.97M Buy
27,216
+1,143
+4% +$119K 0.33% 72
2023
Q3
$2.68M Sell
26,073
-249
-0.9% -$26.8K 0.33% 69
2023
Q2
$3.04M Buy
26,322
+610
+2% +$69.3K 0.35% 66
2023
Q1
$2.74M Sell
25,712
-860
-3% -$92.9K 0.34% 68
2022
Q4
$2.95M Buy
26,572
+245
+0.9% +$25K 0.34% 72
2022
Q3
$2.27M Buy
26,327
+395
+2% +$35.3K 0.31% 73
2022
Q2
$2.36M Sell
25,932
-100
-0.4% -$8.87K 0.3% 75
2022
Q1
$2.14M Buy
26,032
+2,900
+13% +$229K 0.25% 80
2021
Q4
$1.77M Buy
23,132
+295
+1% +$23.5K 0.2% 90
2021
Q3
$1.72M Buy
22,837
+839
+4% +$63.8K 0.21% 87
2021
Q2
$1.71M Buy
21,998
+622
+3% +$46.3K 0.2% 86
2021
Q1
$1.57M Sell
21,376
-4,030
-16% -$297K 0.2% 89
2020
Q4
$1.98M Buy
25,406
+2,107
+9% +$161K 0.27% 79
2020
Q3
$1.84M Hold
23,299
0.28% 78
2020
Q2
$1.72M Sell
23,299
-21
-0.1% -$1.58K 0.27% 78
2020
Q1
$1.71M Buy
23,320
+403
+2% +$31.7K 0.31% 73
2019
Q4
$1.99M Buy
22,917
+331
+1% +$27.2K 0.29% 76
2019
Q3
$1.81M Buy
22,586
+223
+1% +$17.9K 0.28% 77
2019
Q2
$1.79M Hold
22,363
0.28% 77
2019
Q1
$1.77M Sell
22,363
-482
-2% -$36K 0.28% 79
2018
Q4
$1.67M Sell
22,845
-105
-0.5% -$7.41K 0.24% 76
2018
Q3
$1.55M Buy
22,950
+291
+1% +$18.5K 0.21% 83
2018
Q2
$1.31M Buy
22,659
+1,939
+9% +$109K 0.19% 87
2018
Q1
$1.08M Sell
20,720
-524
-2% -$28.3K 0.16% 95
2017
Q4
$1.14M Sell
21,244
-496
-2% -$27.5K 0.18% 89
2017
Q3
$1.33M Buy
21,740
+702
+3% +$42.6K 0.24% 75
2017
Q2
$1.29M Hold
21,038
0.25% 72
2017
Q1
$1.28M Hold
21,038
0.23% 72
2016
Q4
$1.18M Sell
21,038
-392
-2% -$22.9K 0.23% 73
2016
Q3
$1.28M Hold
21,430
0.24% 74
2016
Q2
$1.18M Sell
21,430
-262
-1% -$13.9K 0.22% 78
2016
Q1
$1.09M Buy
21,692
+2,749
+15% +$135K 0.21% 78
2015
Q4
$955K Buy
18,943
+492
+3% +$24.8K 0.2% 79
2015
Q3
$870K Sell
18,451
-846
-4% -$44.9K 0.19% 83
2015
Q2
$1.05M Buy
19,297
+1,397
+8% +$78.3K 0.21% 80
2015
Q1
$982K Buy
17,900
+1,104
+7% +$62.5K 0.19% 83
2014
Q4
$910K Sell
16,796
-419
-2% -$23.3K 0.18% 82
2014
Q3
$974K Buy
17,215
+602
+4% +$33.8K 0.2% 81
2014
Q2
$917K Sell
16,613
-70,159
-81% -$3.83M 0.19% 78
2014
Q1
$4.7M Sell
86,772
-67,757
-44% -$3.51M 1.03% 32
2013
Q4
$7.38M Buy
154,529
+6,253
+4% +$286K 1.67% 21
2013
Q3
$6.74M Buy
148,276
+544
+0.4% +$24.8K 1.72% 20
2013
Q2
$6.55M Buy
+147,732
New +$6.6M 1.65% 22

Other funds holding MRK

Palisade Asset Management's MRK Position: Q2 2026 in Review

Palisade Asset Management increased its Merck (MRK) stake by 0.56% in Q2 2026, buying an estimated $22.9K and bringing the position to 35,395 shares worth $4.55M. The position accounts for 0.42% of the portfolio, ranked #61.

Palisade Asset Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.38M in Q4 2013. 1,153 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Palisade Asset Management held 35,395 shares of Merck worth $4.55M as of Q2 2026.
  • Palisade Asset Management bought 196 Merck shares in Q2 2026, an estimated $22.9K.
  • Merck made up 0.42% of Palisade Asset Management's portfolio in Q2 2026, its #61 holding.
  • Palisade Asset Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Palisade Asset Management's Merck position peaked at $7.38M in Q4 2013.
  • 1,153 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.